-
1
-
-
84879134175
-
Huntington's disease: towards disease modification-gaps and bridges, facts and opinions
-
Reilmann R. Huntington's disease: towards disease modification-gaps and bridges, facts and opinions. Basal Ganglia 2012;2:241-248.
-
(2012)
Basal Ganglia
, vol.2
, pp. 241-248
-
-
Reilmann, R.1
-
2
-
-
84898017417
-
Huntington disease: natural history, biomarkers and prospects for therapeutics
-
Ross CA, Aylward EH, Wild EJ, et al. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol 2014;10:204-216.
-
(2014)
Nat Rev Neurol
, vol.10
, pp. 204-216
-
-
Ross, C.A.1
Aylward, E.H.2
Wild, E.J.3
-
3
-
-
0027480960
-
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. [see comments]
-
The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. [see comments]. Cell 1993;72:971-983.
-
(1993)
Cell
, vol.72
, pp. 971-983
-
-
-
4
-
-
36048961737
-
Huntington's disease phenocopy syndromes
-
Wild EJ, Tabrizi SJ. Huntington's disease phenocopy syndromes. Curr Opin Neurol 2007;20:681-687.
-
(2007)
Curr Opin Neurol
, vol.20
, pp. 681-687
-
-
Wild, E.J.1
Tabrizi, S.J.2
-
5
-
-
68249113963
-
Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data
-
Tabrizi SJ, Langbehn DR, Leavitt BR, et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 2009;8:791-801.
-
(2009)
Lancet Neurol
, vol.8
, pp. 791-801
-
-
Tabrizi, S.J.1
Langbehn, D.R.2
Leavitt, B.R.3
-
6
-
-
83555173501
-
Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data
-
Tabrizi SJ, Reilmann R, Roos RA, et al. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol 2012;11:42-53.
-
(2012)
Lancet Neurol
, vol.11
, pp. 42-53
-
-
Tabrizi, S.J.1
Reilmann, R.2
Roos, R.A.3
-
7
-
-
84879032355
-
Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data
-
Tabrizi SJ, Scahill RI, Owen G, et al. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol 2013;12:637-649.
-
(2013)
Lancet Neurol
, vol.12
, pp. 637-649
-
-
Tabrizi, S.J.1
Scahill, R.I.2
Owen, G.3
-
8
-
-
48249114740
-
Detection of Huntington's disease decades before diagnosis: the Predict-HD study
-
Paulsen JS, Langbehn DR, Stout JC, et al. Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry 2008;79:874-880.
-
(2008)
J Neurol Neurosurg Psychiatry
, vol.79
, pp. 874-880
-
-
Paulsen, J.S.1
Langbehn, D.R.2
Stout, J.C.3
-
9
-
-
84901341459
-
Clinical and biomarker changes in premanifest Huntington disease show trial feasibility: a decade of the PREDICT-HD study
-
Paulsen JS, Long JD, Johnson HJ, et al. Clinical and biomarker changes in premanifest Huntington disease show trial feasibility: a decade of the PREDICT-HD study. Front Aging Neurosci 2014;6:78.
-
(2014)
Front Aging Neurosci
, vol.6
, pp. 78
-
-
Paulsen, J.S.1
Long, J.D.2
Johnson, H.J.3
|